Your browser doesn't support javascript.
loading
Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting.
Inoue, Kenichi; Takahashi, Masato; Mukai, Hirofumi; Yamanaka, Takashi; Egawa, Chiyomi; Sakata, Yukinori; Ikezawa, Hiroki; Matsuoka, Toshiyuki; Tsurutani, Junji.
  • Inoue K; Division of Breast Oncology, Saitama Cancer Center, Saitama, Japan. ino.bad.ken@gmail.com.
  • Takahashi M; Department of Breast Surgery, National Hospital Organization Hokkaido Cancer Center, Hokkaido, Japan.
  • Mukai H; Division of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Yamanaka T; Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
  • Egawa C; Department of Breast Surgery, Kansai Rosai Hospital, Hyogo, Japan.
  • Sakata Y; Clinical Planning and Development Department, Eisai Co., Ltd., Tokyo, Japan.
  • Ikezawa H; Clinical Planning and Development Department, Eisai Co., Ltd., Tokyo, Japan.
  • Matsuoka T; Clinical Planning and Development Department, Eisai Co., Ltd., Tokyo, Japan.
  • Tsurutani J; Advanced Cancer Translational Research Institute, Showa University, Tokyo, Japan.
Invest New Drugs ; 38(5): 1540-1549, 2020 10.
Article en En | MEDLINE | ID: mdl-31950374

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Furanos / Cetonas / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Furanos / Cetonas / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2020 Tipo del documento: Article